Ann Surg27 Aug 2026
Intraoperative adverse events (IAEs) during robot-assisted minimally invasive esophagectomy (RAMIE) can occur in about 8.6% of cases, but most are managed robotically without conversion to open surgery.
JAMA Surg27 Aug 2026
Clinicians face significant challenges when making surgical decisions for patients with dementia due to documentation and communication issues.
Intestine and Lower Gastrointestinal Tract27 Aug 2026
A nomogram can help predict early postoperative deep vein thrombosis (DVT) in gastric and colorectal cancer patients despite routine anticoagulant prophylaxis.
BMC Surg27 Aug 2026
A new consensus from Italian experts offers a standardized, physiology-driven approach to managing appendiceal abscesses, aiming to reduce variability in surgical practice.
Surgical Endoscopy27 Aug 2026
This systematic review shows that Heller's myotomy and peroral endoscopic myotomy (POEM) outperform botulinum toxin for long-term symptom relief in primary achalasia.
Ann Surg26 Aug 2026
A randomized trial reveals no significant cost benefit of robotic pancreatoduodenectomy compared to open surgery, despite higher intraoperative costs.
Ann Surg Oncol26 Aug 2026
Neoadjuvant chemoradiation-immunotherapy offers better pathologic complete response rates compared to neoadjuvant chemoimmunotherapy alone in patients with locally advanced esophageal squamous cell carcinoma, but it comes with increased postoperative pulmonary complications without improving long-term survival.
Ann Surg Oncol26 Aug 2026
In patients with locally advanced esophageal squamous cell carcinoma, neoadjuvant chemoimmunotherapy (ncit) significantly improves three-year overall survival compared to standard chemoradiotherapy (ncrt).
World J Surg26 Aug 2026
In patients undergoing emergency laparotomy, incisional negative pressure wound therapy (INPWT) significantly decreases the risk of surgical site infections (SSI) compared to standard dressings.
J Gastrointest Surg26 Aug 2026
A new study identifies key predictors of early recurrence in gastric cancer patients after curative gastrectomy, developed specifically for a non-East Asian cohort.